Loading...
Phase I studies of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma: a pooled analysis of two phase I studies conducted in Japan and Korea
OBJECTIVE: Two phase I studies of darinaparsin including Japanese and Korean patients with relapsed/refractory peripheral T-cell lymphoma were performed to evaluate its safety (primary purpose), efficacy and pharmacokinetic profile (ClinicalTrials.gov: NCT01435863 and NCT01689220). METHODS: Patients...
Na minha lista:
| Udgivet i: | Jpn J Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869082/ https://ncbi.nlm.nih.gov/pubmed/33051668 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyaa177 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|